264 related articles for article (PubMed ID: 11877288)
1. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.
O'Keeffe M; Hochrein H; Vremec D; Pooley J; Evans R; Woulfe S; Shortman K
Blood; 2002 Mar; 99(6):2122-30. PubMed ID: 11877288
[TBL] [Abstract][Full Text] [Related]
2. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.
Daro E; Pulendran B; Brasel K; Teepe M; Pettit D; Lynch DH; Vremec D; Robb L; Shortman K; McKenna HJ; Maliszewski CR; Maraskovsky E
J Immunol; 2000 Jul; 165(1):49-58. PubMed ID: 10861034
[TBL] [Abstract][Full Text] [Related]
5. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets.
Parajuli P; Mosley RL; Pisarev V; Chavez J; Ulrich A; Varney M; Singh RK; Talmadge JE
Exp Hematol; 2001 Oct; 29(10):1185-93. PubMed ID: 11602320
[TBL] [Abstract][Full Text] [Related]
6. Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4.
Basak SK; Harui A; Stolina M; Sharma S; Mitani K; Dubinett SM; Roth MD
Blood; 2002 Apr; 99(8):2869-79. PubMed ID: 11929777
[TBL] [Abstract][Full Text] [Related]
7. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo.
Pulendran B; Banchereau J; Burkeholder S; Kraus E; Guinet E; Chalouni C; Caron D; Maliszewski C; Davoust J; Fay J; Palucka K
J Immunol; 2000 Jul; 165(1):566-72. PubMed ID: 10861097
[TBL] [Abstract][Full Text] [Related]
8. A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine splenocytes.
Berthier R; Martinon-Ego C; Laharie AM; Marche PN
J Immunol Methods; 2000 May; 239(1-2):95-107. PubMed ID: 10821951
[TBL] [Abstract][Full Text] [Related]
9. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.
Brasel K; De Smedt T; Smith JL; Maliszewski CR
Blood; 2000 Nov; 96(9):3029-39. PubMed ID: 11049981
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.
Sudo Y; Shimazaki C; Ashihara E; Kikuta T; Hirai H; Sumikuma T; Yamagata N; Goto H; Inaba T; Fujita N; Nakagawa M
Blood; 1997 May; 89(9):3186-91. PubMed ID: 9129021
[TBL] [Abstract][Full Text] [Related]
11. Characterization of dendritic cells generated in vivo by an E. coli derived chimeric dual receptor agonist.
Kahn LE; Doshi PD; McGarity KL; Yu M; Bono CP; Lie WR; Rankin AM; Smidt ML; Streeter PR; Klein BK; Welply JK; Woulfe SL
Med Sci Monit; 2002 Dec; 8(12):BR504-14. PubMed ID: 12503028
[TBL] [Abstract][Full Text] [Related]
12. Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers.
Disis ML; Rinn K; Knutson KL; Davis D; Caron D; dela Rosa C; Schiffman K
Blood; 2002 Apr; 99(8):2845-50. PubMed ID: 11929774
[TBL] [Abstract][Full Text] [Related]
13. Flt-3 ligand, in combination with bovine granulocyte-macrophage colony-stimulating factor and interleukin-4, promotes the growth of bovine bone marrow derived dendritic cells.
Hope JC; Werling D; Collins RA; Mertens B; Howard CJ
Scand J Immunol; 2000 Jan; 51(1):60-6. PubMed ID: 10632977
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses.
Weigel BJ; Nath N; Taylor PA; Panoskaltsis-Mortari A; Chen W; Krieg AM; Brasel K; Blazar BR
Blood; 2002 Dec; 100(12):4169-76. PubMed ID: 12393694
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor.
Saunders D; Lucas K; Ismaili J; Wu L; Maraskovsky E; Dunn A; Shortman K
J Exp Med; 1996 Dec; 184(6):2185-96. PubMed ID: 8976174
[TBL] [Abstract][Full Text] [Related]
16. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking.
Xu Y; Zhan Y; Lew AM; Naik SH; Kershaw MH
J Immunol; 2007 Dec; 179(11):7577-84. PubMed ID: 18025203
[TBL] [Abstract][Full Text] [Related]
17. Progenipoietin-generated dendritic cells exhibit anti-tumor efficacy in a therapeutic murine tumor model.
Björck P; Lie WR; Woulfe SL; Klein BK; Olson W; Storkus WJ
Int J Cancer; 2002 Aug; 100(5):586-91. PubMed ID: 12124809
[TBL] [Abstract][Full Text] [Related]
18. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
[TBL] [Abstract][Full Text] [Related]
19. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.
Ebner S; Hofer S; Nguyen VA; Fürhapter C; Herold M; Fritsch P; Heufler C; Romani N
J Immunol; 2002 Jun; 168(12):6199-207. PubMed ID: 12055233
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice.
Björck P
Blood; 2001 Dec; 98(13):3520-6. PubMed ID: 11739152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]